Usefulness of Proteinuria as a Prognostic Marker of Mortality and Cardiovascular Events Among Patients Undergoing Percutaneous Coronary Intervention (Data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial)

Mercado, Nestor; Brugts, Jasper J.; Ix, Joachim H.; Shlipak, Michael G.; Dixon, Simon R.; Gersh, Bernard J.; Lemos, Pedro A.; Guarneri, Mimi; Teirstein, Paul S.; Wijns, William; Serruys, Patrick W.; Boersma, Eric; O'Neill, William W.

doi:10.1016/j.amjcard.2008.06.035

« Previous Next »American Journal of Cardiology
Volume 102, Issue 9 , Pages 1151-1155, 1 November 2008

Usefulness of Proteinuria as a Prognostic Marker of Mortality and Cardiovascular Events Among Patients Undergoing Percutaneous Coronary Intervention (Data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial)

Nestor Mercado, MD, PhD
- Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California
Jasper J. Brugts, MD, MSc
- Department of Interventional Cardiology and Clinical Epidemiology Unit, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
- Corresponding author: Tel: +31-10-703-1528; Fax: +31-10-703-2890
Joachim H. Ix, MD, MAS
- Department of Medicine, Division of Nephrology, University of California, San Francisco, California
Michael G. Shlipak, MD, MPH
- Department of Interventional Cardiology and Clinical Epidemiology Unit, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
- Department of Epidemiology, University of California, San Francisco, California
- Department of Biostatistics, University of California, San Francisco, California
- Section of General Internal Medicine, VA Medical Center, San Francisco, California
Simon R. Dixon, MBChB
- Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan
Bernard J. Gersh, MBChB, DPhil
- Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
Pedro A. Lemos, MD, PhD
- Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil
Mimi Guarneri, MD
- Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California
Paul S. Teirstein, MD
- Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California
William Wijns, MD, PhD
- Cardiovascular Center, O.L.V. Hospital, Aalst, Belgium
Patrick W. Serruys, MD, PhD
- Department of Interventional Cardiology and Clinical Epidemiology Unit, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
Eric Boersma, PhD
- Department of Interventional Cardiology and Clinical Epidemiology Unit, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
William W. O'Neill, MD
- Leonard M. Miller School of Medicine, University of Miami, Miami, Florida